Complain about a product or service

Radiation Therapy May Be Best for Younger Prostate Cancer Patients

May 8, 2006

• Study Links Prostate Cancer to Single Rogue Cell • PSA Testing May Be Unnecessary for Some Older Men • Compound Can Identify Prostate Cancer • Improved PSA Tests May Better Determine Prostate Cancer Risk • Vitamins Don't Cut Prostate Cancer Risk • Aspirin May Lower PSA Levels in Men • FDA Approves New Overactive Bladder Drug • New Prostate Surgical Techniques Often "Over-Promoted" • Feds Approve Drug for Enlarged Prostate • New Prostate Cancer Treatment Shows Promise • Broccoli Reduces Prostate Cancer Risk, Study Finds • Celebrex-Lipitor Combo May Halt Prostate Cancer • Exercise May Speed Prostate Tumor Growth • Soy Compound May Halt Spread of Prostate Cancer • Obesity Linked to Higher Prostate Cancer Mortality • Red Wine May Fight Prostate Cancer • Enlarged Prostate Doesn't Mean Cancer • Hopkins Researchers Claim Better Blood Test for Prostate Cancer • Severe Form of Enlarged Prostate Disease Discovered • Tomato-Broccoli Combo Can Help Shrink Prostate Cancers • Weight Gain Increases Risk of Dying from Prostate Cancer • Smoking Linked to Complications in Prostate Cancer Treatment • Newer Approach Urged in Screening for Aggressive Prostate Cancer • Aspirin May Prevent or Delay Enlarged Prostate • Hopkins Researchers Find Better Blood Test for Prostate Cancer • Prostate Radiation May Cause Problems Later • New Test Detects Prostate Cancer Spread Earlier • Castration May Be Advised in Advanced Prostate Cancer • Radiation Therapy May Be Best for Younger Prostate Cancer Patients • Study Recommends More Prostate Biopsies • Delayed Surgery May Be OK for Some Prostate Cancer Patients • Study: PSA Test Doesn't Improve Prostate Cancer Survival Rate • Prostate Cancer Genes Identified • Annual Prostate Cancer Screening Test Appears to Save Lives • FDA Panel Rejects Prostate Cancer Pill • PSA Test Still Useful, Hopkins Study Finds • No "Normal" PSA Level: Study • New Prostate Cancer Test Shows Promise • Lifestyle and Diet May Stop or Reverse Prostate Cancer Progression

For men under age 55 with localized prostate cancer, external beam radiation may be an effective alternative to both conservative and more invasive treatments, according to a new study published in the June 15, 2006 issue of Cancer.

The study, the first to investigate the outcome of radiation in men under 55 years of age, reveals that external beam radiation therapy is as effective in younger prostate cancer patients as it is in older patients with same-stage localized disease.

Age remains a controversial factor in prostate cancer, with younger age at diagnosis perceived to be associated with more aggressive disease and poorer prognosis. Consequently, physicians tend to recommend more aggressive treatments, such as radical prostatectomy, to younger patients, even those with local, non-metastatic disease.

Older patients diagnosed with similar organ-limited disease, however, are offered more choices, including external beam radiation therapy.

Recently studies have shown that radiation therapy is effective in treating localized prostate cancer in elderly patients and in men under 65 years of age.

Andre Konski, M.D., M.B.A., M.A, Clinical Research Director, Radiation Oncology Department at the Fox Chase Cancer Center in Philadelphia, and colleagues compared how men 55 and under fared five years after diagnosis compared with men between 60 and 69 and men 70 and over, looking at survival, disease progression, and whether blood tests (PSA) showed signs of disease recurrence. All the men had localized prostate cancer and were treated with external beam radiation.

They found no statistically significant differences in the outcomes of these three age groups after five years: 94 percent, 95 percent and 87 percent of patients in each respective age category were alive five years after diagnosis; 96 percent, 97 percent and 98 percent of patients in each respective age category were without metastatic disease; and 82 percent, 76 percent, and 70 percent of patients in each respective age category had no evidence of disease recurrence according to blood.

While this study did not compare radiation with other therapies, "external beam radiation at appropriate dose levels has been shown to be equivalent to permanent prostate seed implant and radical prostatectomy in the treatment of patients with stage T1-2 prostate cancer," said the authors.

Because younger men with localized disease respond as well as older men to radiation, the authors suggest that this less invasive treatment option should be considered for this patient population.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share		Follow us on Twitter.